Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog. - Wikidata - awgldk - TriplyDB

Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.

Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.

http://www.wikidata.org/entity/Q42220886

about

The Elusive Antifibrotic Macrophage Specialized pro-resolving mediators: endogenous regulators of infection and inflammation Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice Amnion Epithelial Cells Promote Lung Repair via Lipoxin A4 15-epi-lipoxin A4 reduces the mortality of prematurely born pups in a mouse model of infection-induced preterm birth.CCR4 Controls the Suppressive Effects of Regulatory T Cells on Early and Late Events during Severe Sepsis.A review of recent developments and applications of morphometry/stereology in lung research.Regulation of inflammation by lipid mediators in oral diseases.An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration.The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases Therapeutic effect of Lipoxin A4 in malaria-induced acute lung injury.Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome.Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis.

P2860

Q26776002-AF92B802-4DAD-4745-AA85-D5BA2FEE8F37 Q28271331-F8D2AABF-33A5-44CB-B755-B00EC45B3567 Q33628879-84730E03-FBE7-4C48-8350-3CD28FC56CCE Q33722569-8A93A05A-7272-4110-AB3F-405C40854A7F Q35236981-43B8C764-891C-4849-93F3-24E3CF34CA29 Q35703434-87A05C7C-109F-44B6-A970-C2B5E7F9176F Q38549538-5619B244-CB8C-402F-86F0-6944C13943B1 Q38899898-BD01997E-1D57-4BED-959B-E7442D41F1AB Q39114374-66452028-4F23-4F64-BBE4-7A9361281061 Q39211384-2C8C9966-DC83-4BAA-9FDC-B455EDB855AA Q48022386-DDBCC0FA-BEAB-434F-908E-148D360BE30D Q52583506-6D30DBD4-9807-40B4-90F1-59A632E84339 Q55355294-8C06622D-4C8C-4D24-93CE-FE5A9257E61A

P2860

Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.

http://www.wikidata.org/entity/Q42220886

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A

@nl

Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.

@en

type

label

Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A

@nl

Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.

@en

prefLabel

Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A

@nl

Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.

@en

P1433

Q42220886-E16EC088-E1E7-497B-87EB-3E29335091B8

P1476

Q42220886-5D415777-30D7-4AA2-8E5C-361DF2AD5DA2

P2093

Q42220886-0745969E-2ACD-401E-BDE3-3153407D8895

Q42220886-0B303728-02E8-4707-8EE4-606BF785953A

Q42220886-4074BF33-B937-4180-8D40-DACA5F30E9D8

Q42220886-44378A60-FC30-4599-A888-15966AD8C977

Q42220886-47525F83-FA5E-48F4-B056-D0CE64D4538A

Q42220886-5A0F5AD6-47C2-4B88-986C-CC2AC8418598

Q42220886-65D7D539-40A3-4F4E-99A2-38FAB8603873

Q42220886-992C116D-2542-4151-A730-3C56845470F0

Q42220886-EEC549F9-8E58-4577-AABB-A63FD4B858D9

P2860

Q42220886-00FFE145-CE77-4E60-BAB0-801EFA6F96F4

Q42220886-0B8FD4D1-6B8B-4184-9C89-7CB65B0C5C2A

Q42220886-0CE821D9-7E9E-4C44-A3B7-1B38AB001C69

Q42220886-101A3782-D924-47FB-A4AC-B770FFB04917

Q42220886-10A27E2F-88E5-42BD-9469-AA884B856D8D

Q42220886-12793604-53F2-42B4-86EB-3AE113CC3540

Q42220886-13001675-4C6C-4E87-BC26-A7C4B9C1B6E5

Q42220886-17C6A065-B8C1-4CFA-80E0-0935BAC560B8

Q42220886-2491B5A1-A0B9-4C0B-9A36-A1B84464692B

Q42220886-29D84640-2585-40BC-9B59-16B714300C97

P304

Q42220886-122BB410-74A1-4A56-ADFE-F7A35EB9F3D8

P31

Q42220886-CC924D0F-2BF8-408F-BACF-84B3BBEC2173

P356

Q42220886-84673863-9528-484F-9876-4ED828E7C540

P433

Q42220886-5557402E-B852-4FD3-906C-748B9B23E9E9

P478

Q42220886-E62643AB-D991-4918-9EB1-F86118AF1EAE

P577

Q42220886-0D3FFA3E-EE68-4DE3-B8FB-50F05BA1C523

P5875

Q42220886-05BECBFF-F8FF-48E4-B5DC-9739781414DA

P698

Q42220886-B2871078-B8A5-4E07-9242-D9813525E5BC

P921

Q42220886-6EE4865F-73A3-4829-90A7-E12EB7974A69

P932

Q42220886-7FBEFD52-CDFC-47EF-827E-2CB35521A381

P356

RCMB.2012-0462OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.

@en

P2093

Claudia F Benjamim

http://www.w3.org/2001/XMLSchema#string

Claudio Canetti

http://www.w3.org/2001/XMLSchema#string

Célio G Freire-de-Lima

http://www.w3.org/2001/XMLSchema#string

Debora G Xisto

http://www.w3.org/2001/XMLSchema#string

Iolanda M Fierro

http://www.w3.org/2001/XMLSchema#string

Josiane S Neves

http://www.w3.org/2001/XMLSchema#string

Patricia R M Rocco

http://www.w3.org/2001/XMLSchema#string

Rafael F Guilherme

http://www.w3.org/2001/XMLSchema#string

Steven L Kunkel

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

Cellular and molecular mechanisms of fibrosis

Exploring the full spectrum of macrophage activation

Soluble TNF mediates the transition from pulmonary inflammation to fibrosis

Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins

Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution

Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo

Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation

Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin-triggered lipid mediators

Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo

P304

1029-1037

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2012-0462OC

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249317172

http://www.w3.org/2001/XMLSchema#string

P698

23848293

http://www.w3.org/2001/XMLSchema#string

P921

P932

5459549

http://www.w3.org/2001/XMLSchema#string